Worth reading
12Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Avoiding a definitive answer
How definitive the wording is.Items stated in the management plan
Publication date5 November 2026
This document does not state the plan name, plan period, or numerical targets.
Key initiatives
01Promote the provision of cybersecurity services to medical institutions
02Build a comprehensive support structure covering security assessments, improvement proposals and operational support
03Expand the customer base and strengthen the revenue base in Japan's Tech sector
Size of the Target MarketMarket Japan's healthcare, health care and pharmaceutical DX-related markets / 2025 ¥781.8 billion / 2030 A market exceeding ¥1 trillion / Source Fuji Keizai, “Current Status and Future Outlook of the Healthcare, Health Care and Pharmaceutical DX-Related Markets, 2025 Edition”
Risks identified by the company
Ransomware attacks
Data-breach incidents
Security risks involving sensitive personal information, including patient information and medical records
| Item | Details |
|---|---|
| Key initiatives | Promote the provision of cybersecurity services to medical institutions, Build a comprehensive support structure covering security assessments, improvement proposals and operational support, Expand the customer base and strengthen the revenue base in Japan's Tech sector |
| Size of the Target Market | Market Japan's healthcare, health care and pharmaceutical DX-related markets / 2025 ¥781.8 billion / 2030 A market exceeding ¥1 trillion / Source Fuji Keizai, “Current Status and Future Outlook of the Healthcare, Health Care and Pharmaceutical DX-Related Markets, 2025 Edition” |
| Risks identified | Ransomware attacks, Data-breach incidents, Security risks involving sensitive personal information, including patient information and medical records |
| Publication date | 5 November 2026 |
Items this document does not state (21)
Plan namePlan periodProgress against the planSales TargetOperating profit targetOperating profit margin targetNet income targetROE targetROIC targetPayout ratio / DOE policyTreasury share acquisition policyCost of capitalSelf-assessment of PBR and share priceTotal investment planInvestment amount by sectorSegment targetNon-financial targetsPlan assumptionsResults under the previous planReason for revision or withdrawalDate of board resolution
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The Company views the growth of the healthcare DX market and rising demand for cybersecurity and social expectations as growth opportunities, and aims to use them to build a new customer base and strengthen its revenue base.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.